Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: January

Request Number: A-2022-000999

Request Summary: The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the Good Clinical Practices (GCP) inspection of Phase 2 for the Methylenedioxy​methamphetamine (MDMA) trial by the Multidisciplinary Association for Psychedelic Studies facility on Stevens Creek Blvd, San Jose, California, USA, starting around 6 June 2022. Control Number 240514.

Disposition: Disclosed in part

Number of pages: 11

Date modified: